Sanlam Emerging Markets has increased its shareholding in India’s Shriram Life Insurance Company Limited, completing a previously announced transaction at a time when Asia-Pacific deal activity is mixed across asset classes and markets.
According to Market Screener’s report, Sanlam Emerging Markets (Mauritius) Limited has closed the acquisition of an additional 14.72% interest in Shriram Life Insurance from Piramal Finance Limited for a cash consideration of INR 6 billion. The transaction was completed on March 30, 2026, after receiving the required regulatory approvals. The deal is based on a share purchase agreement signed on Dec. 19, 2025. Under that agreement, Sanlam committed to pay INR 6 billion, with the amount allocated to the common equity of Shriram Life. Following completion, Sanlam Emerging Markets’ ownership in the Indian life insurer stands at 37.72%.
Read next: APAC insurance M&A outpaces other regions
The acquisition was subject to clearance by relevant regulatory boards and committees, with completion targeted for the quarter ending March 31, 2026. That schedule has now been met with the transfer of the 14.72% stake from Piramal Finance, which is listed on the National Stock Exchange of India under the symbol PIRAMALFIN. For the financial period ended March 31, 2025, Shriram Life Insurance Company Limited reported total revenue of INR 126.8 million. The company operates in India’s life insurance market, where foreign shareholders frequently adjust their positions over time through incremental share purchases alongside domestic partners.
The Sanlam-Shriram Life transaction has closed against a backdrop of softer overall deal volumes in the Asia-Pacific (APAC) region in early 2026. Across mergers and acquisitions (M&A), private equity, and venture financing, the total number of deals announced in APAC declined by around 6% in January-February 2026 compared with the same period in 2025, according to GlobalData’s analysis of its Financial Deals Database.
Deal activity moved differently by type. Announced M&A transactions in APAC fell 32% year-on-year over the first two months of 2026, while private equity deal counts more than halved. Venture financing deals went in the opposite direction, with GlobalData reporting a 28% year-on-year increase in volume. “While the growth in venture financing is encouraging, the significant declines in M&A and private equity highlight the challenges facing the APAC deals landscape, reflecting broader economic uncertainties that have dampened deal-making sentiments,” said Aurojyoti Bose, lead analyst at GlobalData.
GlobalData’s breakdown of activity by country points to differing trends across major APAC markets. China recorded a 47% year-on-year increase in announced deals during January-February 2026 compared with the same months in 2025, which helped offset lower volumes in other markets. India, Japan, Australia, and South Korea all saw declines over the same period. Deal volumes fell by 5% in India, 51% in Japan, 17% in Australia, and 26% in South Korea on a year-on-year basis, reflecting a more subdued pipeline in several of the region’s larger economies. GlobalData notes that historical figures may change as additional transactions are disclosed with a lag in the public domain, which can alter previously reported monthly totals.
Sanlam’s additional investment in Shriram Life signals that interest in Indian life insurance assets remains active despite a broader slowdown in M&A and private equity deal counts across APAC. The transaction is in line with a pattern of international groups adjusting ownership levels in local insurance entities through selective stake increases rather than focusing only on large control acquisitions. At the same time, the rise in venture financing suggests that capital remains available for businesses in areas such as insurtech, digital distribution, and data or analytics, which intersect with insurance operating models and distribution strategies. In the near term, insurance executives and corporate development teams considering inorganic growth in Asia may continue to evaluate minority stake increases, joint ventures, and portfolio adjustments, while monitoring regulatory developments, valuation conditions, and macroeconomic trends across the region’s key insurance markets.
